Functional Trajectories of Persons with Cardiovascular Disease in Late Life.


Journal

Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062

Informations de publication

Date de publication:
01 2019
Historique:
received: 31 01 2018
revised: 02 08 2018
accepted: 02 08 2018
pubmed: 22 11 2018
medline: 26 11 2019
entrez: 22 11 2018
Statut: ppublish

Résumé

Physical function declines with aging and is accelerated for persons with cardiovascular disease (CVD). While CVD increases the risk of functional decline in late life, little is known about differences in trajectories of functional decline. To determine whether there is more than 1 trajectory of functional decline in Americans with cardiovascular disease (CVD) who are functionally independent. Secondary analysis of National Health and Aging Trends Study (NHATS). Latent class growth modeling was used to estimate trajectories of function over 4 years of follow-up. Annual structured in-home interviews. Americans aged 65 and older with CVD who were functionally independent at baseline (N = 392). We compared trajectories of function in individuals with CVD with trajectories of those without and examined the association between risk factors (sex, age at baseline, education level, comorbidity) and trajectory group membership. Function was measured using the Short Physical Performance Battery. Three functional trajectories emerged: rapid functional decline (23.8%), gradual functional decline (44.2%), and stable function (32.0%). Similar trajectories were seen for those without CVD, with a smaller proportion in the rapid functional decline group (16.2%). Women, older participants, and those with less education and greater comorbidity were less likely to be in the stable function group than the rapid functional decline group. Although function declines in late life for independently functioning persons with CVD, some individuals remain stable, and others decline gradually or rapidly. Persons with CVD were more likely to experience rapid functional decline than those without, suggesting that CVD increases the risk of rapid functional decline. Risk factors predicted functional trajectory group membership, not just overall decline. J Am Geriatr Soc 67:37-42, 2019.

Identifiants

pubmed: 30460975
doi: 10.1111/jgs.15584
pmc: PMC6705121
mid: NIHMS1042139
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

37-42

Subventions

Organisme : NIA NIH HHS
ID : U01 AG032947
Pays : United States

Informations de copyright

© 2018, Copyright the Authors Journal compilation © 2018, The American Geriatrics Society.

Références

Soc Sci Med. 1999 Feb;48(4):445-69
pubmed: 10075171
Am J Epidemiol. 1996 Apr 15;143(8):766-78
pubmed: 8610686
J Sport Exerc Psychol. 2007 Feb;29(1):100-17
pubmed: 17556778
Circ Cardiovasc Qual Outcomes. 2014 Nov;7(6):863-71
pubmed: 25387772
Circulation. 2011 Mar 1;123(8):933-44
pubmed: 21262990
Science. 2002 May 10;296(5570):1029-31
pubmed: 12004104
Int J Epidemiol. 2016 Aug;45(4):1135-1145
pubmed: 27272182
J Aging Phys Act. 2015 Apr;23(2):314-22
pubmed: 24812254
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
J Gerontol A Biol Sci Med Sci. 2016 Aug;71(8):1056-62
pubmed: 27071781
J Gerontol A Biol Sci Med Sci. 2016 Mar;71 Suppl 1:S79-86
pubmed: 26858328
Health Aff (Millwood). 2007 Jan-Feb;26(1):38-48
pubmed: 17211012
Soc Sci Med. 1994 Jan;38(1):1-14
pubmed: 8146699
J Gerontol A Biol Sci Med Sci. 2015 Mar;70(3):332-8
pubmed: 25060316
J Gerontol A Biol Sci Med Sci. 2015 Nov;70(11):1427-34
pubmed: 26297656
Am J Med. 2011 Sep;124(9):827-33.e5
pubmed: 21722862
J Gerontol B Psychol Sci Soc Sci. 2015 Jul;70(4):661-71
pubmed: 25161216
J Am Coll Cardiol. 2017 Apr 18;69(15):1952-1967
pubmed: 28408026
J Am Geriatr Soc. 2006 May;54(5):743-9
pubmed: 16696738
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
Circulation. 2017 Apr 18;135(16):e894-e918
pubmed: 28336790
J Am Geriatr Soc. 2002 Sep;50(9):1525-34
pubmed: 12383150
J Am Geriatr Soc. 1998 Jun;46(6):677-82
pubmed: 9625181

Auteurs

Tamra Keeney (T)

MGH Institute of Health Professions, Boston, Massachusetts.

Annie B Fox (AB)

MGH Institute of Health Professions, Boston, Massachusetts.

Diane U Jette (DU)

MGH Institute of Health Professions, Boston, Massachusetts.

Alan Jette (A)

MGH Institute of Health Professions, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH